Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025)
Pulmonx has reported Depreciation & Amortization (CF) over the past 7 years, most recently at $246000.0 for Q3 2025.
- Quarterly Depreciation & Amortization (CF) fell 34.57% to $246000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $823000.0 through Dec 2025, down 44.88% year-over-year, with the annual reading at $1.5 million for FY2024, 3.55% down from the prior year.
- Depreciation & Amortization (CF) was $246000.0 for Q3 2025 at Pulmonx, down from $299000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $437000.0 in Q1 2023 and troughed at $141000.0 in Q1 2021.
- The 5-year median for Depreciation & Amortization (CF) is $374000.0 (2021), against an average of $328631.6.
- Year-over-year, Depreciation & Amortization (CF) skyrocketed 192.19% in 2021 and then crashed 34.57% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $374000.0 in 2021, then increased by 3.21% to $386000.0 in 2022, then dropped by 25.65% to $287000.0 in 2023, then grew by 2.44% to $294000.0 in 2024, then dropped by 16.33% to $246000.0 in 2025.
- Per Business Quant, the three most recent readings for LUNG's Depreciation & Amortization (CF) are $246000.0 (Q3 2025), $299000.0 (Q2 2025), and $278000.0 (Q1 2025).